Skip to main content
AI Market Watch
Loading...

injewelme

Category: AI in Healthcare

Singapore-based AI healthtech company specializing in contactless vital signs monitoring via remote photoplethysmography (rPPG) and predictive AI models. injewelme was founded in 2020. The company is led by Geemyung Moon (James Moon). Based in Singapore (HQ); Seoul, South Korea (R&D/Operations). Team size: 1-10. Total funding raised: $1.2M. Latest round: Seed. Key investors include Catalytic Capital for Climate and Health (C3H) / Temasek Trust, Richardson Family (UK family office), CNTTECH (Korea venture accelerator, prior investor).

Founded
2020
Headquarters
Singapore (HQ); Seoul, South Korea (R&D/Operations)
Team size
1-10
Total funding
$1.2M

Value proposition

Contactless health monitoring of 20+ vital parameters (heart rate, blood pressure, oxygen saturation, etc.) in ~30 seconds using a standard camera, with 95% detection accuracy in real-world pilots.

Products and solutions

DeepHealthVision (DHV) — contactless vital signs monitoring platform using rPPG, DeepHealthNet — AI model architecture, WUD! (Would U Do It!/우주두잇) — gamified children's obesity management app

Unique value

Industry-leading 95% detection accuracy in real-world settings; contactless monitoring via any standard camera; time-series health data platform bridging personal and clinical records; human-in-the-loop AI approach.

Target customer

Healthcare systems (polyclinics, hospitals), eldercare facilities, insurance companies, workplace safety programs, and active ageing centres

Industries served

Healthcare, Eldercare, Insurance, Workplace Safety, Corporate Wellness

Technology advantage

Proprietary rPPG-based DeepHealthVision (DHV) technology; predictive AI models trained on time-series health big data; cross-platform software solution (DeepHealthNet); 18 registered intellectual properties; government R&D grants (over 1 billion KRW); research featured in IEEE JBHI.

How they differentiate

Validated in real-world conditions (not just controlled settings) with SingHealth Polyclinics; 95% accuracy in live pilots; 20+ health parameters from a single 30-second video; time-series data platform for continuous tracking; gamified approach for pediatric health via WUD! app; 18 registered IP assets.

Main competitors

Binah.ai (Israel), NuraLogix (Canada), FaceHeart (Taiwan)

Key partnerships

SingHealth Polyclinics (clinical trials), SJ Group / SJ Integrated Solutions (active ageing centres), C3H / Temasek Trust (strategic partner & investor), Richardson Family (UK family office), Co-Axis (digital impact marketplace), Chungbuk National University (R&D collaboration), Seoul AI Hub

Notable customers

SingHealth Polyclinics (Singapore public healthcare), SJ Integrated Solutions (senior fitness & wellness programmes), 80+ elementary schools in South Korea (WUD! app)

Major milestones

2020: Company founded in South Korea (injewelme Co., Ltd.), 2021: Seed funding from CNTTECH, 2022: Government R&D grants (TIPS program), 2024: 18 IP assets registered, Research featured in IEEE JBHI, 2025: Relocated HQ to Singapore (injewelme PTE. LTD.), Partnership with SJ Group, Trials with SingHealth Polyclinics, 2026: $1.2M seed round led by Temasek Trust's C3H with Richardson Family

Growth metrics

Tested by 100,000+ users in South Korea; 95% detection accuracy in real-world pilots; deployed in 80+ elementary schools in Korea; reduced pre-activity screening time by ~50% for SJ Group

Market positioning

Early-stage AI healthtech company positioned at the intersection of climate health and contactless monitoring, with strong institutional backing from Temasek Trust's C3H. Focused on Southeast Asian expansion after initial validation in Singapore and South Korea.

Geographic focus

Singapore (primary); Southeast Asia (expansion target); South Korea (established presence)

Patents and IP

18 registered intellectual properties (as of 2024); 2 technology patents filed in Singapore (2025); 3 registered patents in Korea

About Geemyung Moon (James Moon)

Ex-Samsung Electronics (15+ yrs in Business Planning & Strategy); AIG MBA; National University of Singapore

Latest news about injewelme

More AI in Healthcare companies

Official website: